These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6938189)

  • 21. Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.
    Lara M; Oakley GD; Rowbotham D
    Br Med J; 1980 Jul; 281(6234):198. PubMed ID: 7407521
    [No Abstract]   [Full Text] [Related]  

  • 22. Ventricular tachycardia after disopyramide.
    Siklos P; Chalmers TM; Evans DW
    Lancet; 1978 Jan; 1(8055):98-9. PubMed ID: 74597
    [No Abstract]   [Full Text] [Related]  

  • 23. [Electrocardiographic disturbances induced by the simultaneous administration of indapamide and disopyramide].
    Cosma C; Pauly-Laubry C; Py J
    Nouv Presse Med; 1978 Nov; 7(38):3455. PubMed ID: 740527
    [No Abstract]   [Full Text] [Related]  

  • 24. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disopyramide.
    Morady F; Scheinman MM; Desai J
    Ann Intern Med; 1982 Mar; 96(3):337-43. PubMed ID: 7036817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
    Forester D
    Chest; 1979 Jun; 75(6):745. PubMed ID: 436537
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR
    J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinidine effects due to disopyramide.
    Frieden J
    N Engl J Med; 1978 Apr; 298(17):975. PubMed ID: 642984
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
    Ophoff N; Toker Y
    Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some cardiovascular problems with disopyramide.
    Warrington SJ; Hamer J
    Postgrad Med J; 1980 Apr; 56(654):229-33. PubMed ID: 7433320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac arrhythmias associated with disopyramide.
    Kinney EL; Field EH; Salmon MP; Zelis R
    N Engl J Med; 1980 May; 302(20):1146. PubMed ID: 7366640
    [No Abstract]   [Full Text] [Related]  

  • 32. Extreme tachycardia complicating the use of disopyramide in atrial flutter.
    Robertson CE; Miller HC
    Br Heart J; 1980 Nov; 44(5):602-3. PubMed ID: 7437205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 34. Myocardial depression with disopyramide.
    Bauman DJ
    Ann Intern Med; 1981 Mar; 94(3):411-2. PubMed ID: 7224397
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentially fatal interaction between erythromycin and disopyramide.
    Ragosta M; Weihl AC; Rosenfeld LE
    Am J Med; 1989 Apr; 86(4):465-6. PubMed ID: 2467560
    [No Abstract]   [Full Text] [Related]  

  • 36. Congestive heart failure caused by oral disopyramide.
    Podrid PJ; Schoeneberger A; Lown B
    N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia.
    Vismara LA; Vera Z; Miller RR; Mason DT
    Am J Cardiol; 1977 Jun; 39(7):1027-34. PubMed ID: 326016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.
    Kerr CR; Prystowsky EN; Smith WM; Cook L; Gallagher JJ
    Circulation; 1982 May; 65(5):869-78. PubMed ID: 6804107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.